Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -16.36% | 57.71 | 0.0% | $1537.44m | |
| GILD | Gilead Sciences, Inc. | -0.22% | 73.18 | 1.0% | $1287.43m | |
| AMGN | Amgen, Inc. | -1.78% | 222.40 | 1.3% | $637.47m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -4.33% | 545.21 | 2.5% | $616.99m | |
| NVAX | Novavax, Inc. | 4.47% | 48.17 | 102.0% | $608.66m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -6.48% | 266.50 | 1.9% | $516.32m | |
| BIIB | Biogen, Inc. | -2.84% | 295.87 | 1.6% | $413.02m | |
| ILMN | Illumina, Inc. | -0.08% | 354.41 | 3.5% | $354.75m | |
| SRNE | Sorrento Therapeutics, Inc. | 3.95% | 5.27 | 1.8% | $307.06m | |
| SGEN | Seattle Genetics, Inc. | -2.59% | 151.73 | 6.1% | $243.04m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.28% | 102.80 | 2.0% | $224.06m | |
| A | Agilent Technologies, Inc. | 1.37% | 86.14 | 1.6% | $196.15m | |
| CODX | Co-Diagnostics, Inc. | -2.80% | 18.03 | 0.0% | $185.93m | |
| MGNX | MacroGenics, Inc. | -6.82% | 23.64 | 6.2% | $178.27m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 6.39% | 103.74 | 4.3% | $172.63m |
Company Profile
Xenetic Biosciences, Inc. engages in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient's malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.